The latest information on Multiple Sclerosis authored by renowned experts.
Clinical relapses and MRI measures of disease activity provide convenient means for the physician to monitor disease activity, but the accumulation of disability is the most relevant metric for patients...
Read MoreTherapeutic macromolecules (eg, monoclonal antibodies, nucleic acids, pathogen surface proteins used as vaccines) elicit an immune response that results in the production of binding antibodies...
Read MoreFor the past decade, three general approaches to the treatment of relapsing-remitting multiple sclerosis (RRMS) have been available...
Read MoreAn understanding of the immunology of multiple sclerosis (MS) will be increasingly important as new therapies emerge...
Read MorePatients newly diagnosed with multiple sclerosis (MS) must come to terms with not only the realization that they have a chronic disease, but also the knowledge that they are facing a lifetime of therapy...
Read MoreThe most basic diagnostic principle for multiple sclerosis (MS) is dissemination of lesions in time and space. This must be demonstrated in the absence of a more likely explanation...
Read MoreMultiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system. Although MS has a highly variable clinical course,...
Read MoreThe causative factors of multiple sclerosis (MS) have remained elusive ever since the first description of the disease in the late 1800s...
Read More